“We are what we eat!” Invasive intestinal mucormycosis: A case report and review of the literature

Medical Mycology Case Reports

Volumn 1, Issue 1, 2012, Pages 52-55

  Martinello, Marianne ^a   Nelson, Adam ^a   Bignold, Leon ^b   Shaw, David ^a  

^a ROYAL ADELAIDE HOSPITAL   (Australia)

^b INSTITUTE OF MEDICAL AND VETERINARY SCIENCE   (Australia)

Author keywords

Gastrointestinal; Jejunum; Mucormycosis; Rhizopus

Indexed keywords

AMPHOTERICIN B LIPID COMPLEX; ANTIFUNGAL AGENT; ISAVUCONAZOLE; POSACONAZOLE; VORICONAZOLE;

ACUTE ABDOMEN; ACUTE DIARRHEA; ACUTE KIDNEY FAILURE; ADULT; ALCOHOL ABUSE; ARTICLE; BEER; CASE REPORT; CLINICAL ARTICLE; DISEASE COURSE; DRUG MONITORING; GASTROINTESTINAL INFECTION; HISTOLOGY; HUMAN; HUMAN TISSUE; ILEUM; INVASIVE INTESTINAL MUCORMYCOSIS; JEJUNUM; JEJUNUM DISEASE; LAPAROTOMY; MALE; MALNUTRITION; MIDDLE AGED; MUCORALES; MUCORMYCOSIS; PERITONITIS; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; RHIZOPUS; RISK FACTOR; RURAL AREA; SALMONELLA ENTERICA SEROVAR TYPHIMURIUM; SALVAGE THERAPY; SMALL INTESTINE OBSTRUCTION; SMALL INTESTINE PERFORATION; SOUTH AUSTRALIA; TREATMENT RESPONSE;

EID: 84865331645     PISSN: 22117539     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mmcr.2012.07.003     Document Type: Article

References (20)

1. Kwon-Chung, K., Taxonomy of fungi causing mucormycosis and entomophthoramycosis (zygomycosis) and nomenclature of the disease: molecular and mycologic perspectives. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 54:S1 (2012), S8–S15.
2. Roden, M., Zaoutis, T., Buchanan, W., Knudsen, T., Sarkisova, T., Schaufele, R., et al. Epidemiology and outcome of zygomycosis: a review of 929 reported cases. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 41 (2005), 634–653.
3. Petrikkos, G., Skiada, A., Lortholary, O., Roilides, E., Walsh, T., Kontoyiannias, D., Epidemiology and clinical manifestations of mucormycosis. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 54:S1 (2012), S23–S34.
4. Lanternier, F., Dannaoui, E., Morizot, G., Elie, C., Garcia-Hermoso, D., Huerre, M., et al. A global analysis of mucormycosis in France: the RetroZygo study (2005–2007). Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 54:S1 (2012), S35–S43.
5. Agha, F., Horchang, L., Boland, C.R., Bradley, S., Mucormycoma of the colon: early diagnosis and successful management. American Journal of Roentgenology 145 (1985), 739–741.
6. Spellberg, B., Gastrointestinal mucormycosis: an evolving disease. Gastroenterology and Hepatology 8:2 (2012), 140–142.
7. Lau, A., Chen, S., Sorrell, T., Carter, D., Malik, R., Martin, P., et al. Development and clinical application of a panfungal PCR assay to detect and identify fungal DNA in tissue specimens. Journal of Clinical Microbiology 45:2 (2007), 380–385.
8. Zaoutis, T., Roilides, E., Chiou, C., Buchanan, W., Knudsen, T., Sarkisova, T., et al. Zygomycosis in children: a systematic review and analysis of reported cases. The Pediatric Infectious Disease Journal 26:8 (2007), 723–727.
9. Oliver, M.R., Van Voorhis, W.C., Boeckh, M., Mattson, D., Bowden, R., et al. Hepatic mucormycosis in a bone marrow transplant recipient who ingested naturopathic medicine. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 22 (1996), 521–524.
10. Maravi-Poma, E., Rodriguez-Tudela, J.L., de Jalon, J.G., Outbreak of gastric mucormycosis associated with the use of wooden tongue depressors in critically ill patients. Intensive Care Medicine 30 (2004), 724–728.
11. Prabhu, R.M., Patel, R., Mucormycosis and entomophthoracmycosis: a review of the clinical manifestations, diagnosis and treatment. Clinical Microbiology and Infection 10:S1 (2004), 31–47.
12. Spellberg, B., Walsh, J., Kontoyiannis, D., Edwards, J., Ibrahim, A., Recent advances in the management of mucormycosis: from bench to bedside. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 48 (2009), 1743–1751.
13. Chamilos, G., Lewis, R.E., Kontoyiannis, D.P., Delaying amphotericin B-based frontline therapy significantly increases mortality among patients with hematologic malignancy who have zygomycosis. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America, 47, 2008, 503.
14. Dannaoui, E., Molecular tools for identification of zygomycetes and the diagnosis of zygomycosis. Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 15:S5 (2009), 66–70.
15. Kasai, M., Harrington, S.M., Francesconi, A., Petraitis, V., Petraitiene, R., Beveridge, M., et al. Detection of a molecular biomarker for Zygomycetes by quantitative PCR assays of plasma, bronchoalveolar lavage, and lung tissue in a rabbit model of experimental pulmonary zygomycosis. Journal of Clinical Microbiology 46 (2008), 3690–3702.
16. Spellberg, B., Ibrahim, A., Roilides, E., Lewis, R., Lortholary, O., Petrikkos, G., et al. Combination therapy for mucormycosis: why, what, and how?. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 54:S1 (2012), S73–S78.
17. Reed, C., Bryant, R., Ibrahim, A.S., Combination polyene-caspofungin treatment of rhino-orbital-cerebral mucormycosis. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 47 (2008), 364–371.
18. Spellberg, B., Ibrahim, A.S., Chin-Hong, P.V., Kontoyiannia, D., Morris, M., Fredericks, D., et al. The Deferasirox-AmBisome therapy for mucormycosis (DEFEAT Mucor) study: a randomized, double-blinded, placebo-controlled trial. The Journal of Antimicrobial Chemotherapy 67:3 (2012), 715–722.
19. Greenberg, R., Mullane, K., Van Burik, A., Posaconazole as salvage therapy for zygomycosis. Antimicrobial Agents and Chemotherapy 50:1 (2006), 126–133.
20. Ibrahim, A.S., Gebremariam, T., Schwartz, J.A., Edwards, jr. JE, Spellberg, B., Posaconazole mono- or combination therapy for treatment of murine zygomycosis. Antimicrobial Agents and Chemotherapy 53 (2009), 772–775.